Dexamethasone and 11-dehydrodexamethasone as tools to investigate the isozymes of 11β-hydroxysteroid dehydogenase in vitro and in vivo

Journal of Endocrinology

Volumn 153, Issue 1, 1997, Pages 41-48

  Best, R ^a   Nelson, S M ^a   Walker, B R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

11 DEHYDRODEXAMETHASONE; 11BETA HYDROXYSTEROID DEHYDROGENASE; DEXAMETHASONE; ISOENZYME; UNCLASSIFIED DRUG;

ADULT; ARTICLE; DRUG DETERMINATION; DRUG METABOLISM; ENZYME ACTIVITY; GAS CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; INDIVIDUALITY; INTRAVENOUS DRUG ADMINISTRATION; MALE; MASS SPECTROMETRY; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0030903739     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1530041     Document Type: Article

References (31)

1. +-dependent isoform of 11β-hydroxysteroid dehydrogenase. Cloning and characteristaion of cDNA from sheep kidney. Journal of Biological Chemistry 269 25959-25962.
2. Albiston AL, Obeyesekere VR, Smith RE & Krozowski ZS 1994 Cloning and tissue distribution of the human 11β-hydroxysteroid dehydrogenase type 2 enzyme. Molecular and Cellular Endocrinology 105 R11-R17.
3. Brown RW, Chapman KE, Kotelevtsev Y, Yau J, Lindsay RM, Brett L, Leckie C, Murad P, Lyons V, Mullins JJ, Edwards CRW & Seckl JR 1996 Cloning and production of antisera to human placental 11β-hydroxysteroid dehydrogenase Type 2. Biochemical Journal 313 1007-1017.
4. Edwards CRW, Burt D, McIntyre MA, De Kloet ER, Stewart PM, Brett L, Sutanto WS & Monder C 1988 Localisation of 11β-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor. Lancet 2 986-989.
5. Guthrie S 1991 The impact of dexamethasone pharmacokinetics on the DST: a review. Psychopharmacology Bulletin 27 565-576.
6. Ichigashira N & Yamaga N 1978. Intraocular fate of dexamethasone disodium phosphate topically applied to the eyes of rabbits. Steroids 32 615-628.
7. Kaye TB & Crapo L 1990 The Gushing syndrome: an update on diagnostic tests. Annals of Internal Medicine 112 434-444.
8. Lowy MT & Meltzer HY 1987 Dexamethasone bioavailability: implications for DST research. Biological Psychiatry 22 373-385.
9. Miekle AW 1982 Dexamethasone suppression tests: usefulness of simultaneous measurement of plasma Cortisol and dexamethasone. Clinical Endocrinology 16 401-408.
10. Minigawa K, Kasuya Y, Baba S, Knapp G & Skelly JP 1985 Determination of dexamethasone in human plasma and urine by electron-impact mass spectrometry. Journal of Chromatography 343 231-237.
11. Monder C, Stewart PM, Lakshmi V, Valentino R, Burt D & Edwards CRW 1989 Licorice inhibits corticosteroid 11β-dehydrogenase of rat kidney and liver: in vivo and in vitro studies. Endocrinology 125 1046-1053.
12. Monder C, Lakshmi V & Miroff Y 1991 Kinetic studies on rat liver 11β-hydroxysteroid dehydrogenase. Biochimica et Biophysica Acta 1115 23-29.
13. Obeyeskere VR, Ferrari P, Andrews RK, Wilson RC, New MI, Funder JW & Krozowski ZS 1995 The R337C mutation generates a high Km 11β-hydroxysteroid dehydrogenase type II enzyme in a family with apparent mineralocorticoid excess. Journal of Clinical Endocrinology and Metabolism 80 3381-3383.
14. Phillipou G & Higgins BA 1985. A new defect in the peripheral conversion of cortisone to Cortisol. Journal of Steroid Biochemistry 22 435-436.
15. Rajan V, Edwards CRW & Seckl JR 1996 11β-Hydroxysteroid dehydrogenase in cultured hippocampal cells reactivates inert 11-dehydrocorticosterone, potentiating neurotoxicity. Journal of Neuroscience 16 65-70.
16. Rodin A, Thakker H, Taylor N & Clayton R 1994 Hyperandrogenism in polycystic ovarian syndrome: evidence of dysregulation of 11beta-hydroxysteroid dehydrogenase. New England Journal of Medicine 330 460-465.
17. Shackleton CHL & Honour J 1976 Simultaneous estimation of urinary steroids by semi-automated gas chromatography. Investigation of neo-natal infants and children with abnormal steroid synthesis. Clinica Chimica Acta 69 267-283.
18. Siebe H, Baude G, Lichtenstein I, Wang D, Buhler H, Hoyer G-A & Hierholzer K 1993 Metabolism of dexamethasone: sites and activity in mammalian tissues. Renal Physiology and Biochemistry 16 79-88.
19. Soro A, Ingram MC, Tonolo G, Glorioso N & Fraser R 1995 Evidence of coexisting changes in 11β-hydroxysteroid dehydrogenase and 5β-reductase activity in patients with untreated essential hypertension. Hypertension 25 67-70.
20. Stewart PM, Wallace AM, Atherden SM, Shearing CH & Edwards CRW 1990 Mineralocorticoid activity of carbenoxolone: contrasting effects of carbenoxolone and liquorice on 11β-hydroxysteroid dehydrogenase activity in man. Clinical Science 78 49-54.
21. Ulick S, Levine LS, Gunczler P, Zanconato G, Ramirez LC, Rauh W, Rosler A, Bradlow HL & New MI 1979 A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol. Journal of Clinical Endocrinology and Metabolism 49 757-764.
22. Ulick S, Tedde R & Mantero F 1990 Pathogenesis of the type 2 variant of the syndrome of apparent mineralocorticoid excess. Journal of Clinical Endocrinology and Metabolism 70 200-206.
23. Walker BR & Best R 1995 Clinical investigation of 11beta-hydroxysteroid dehydrogenase. Endocrine Research 4 379-387.
24. Walker BR, Yau JL, Brett LP, Seckl JR, Monder C, Williams BC & Edwards CRW 1991 11β-Hydroxysteroid dehydrogenase in vascular smooth muscle and heart: implications for cardiovascular responses to glucocorticoids. Endocrinology 129 3305-3312.
25. Walker BR, Campbell JC, Fraser R, Stewart PM & Edwards CRW 1992a Mineralocorticoid excess and inhibition of 11β-hydroxysteroid dehydrogenase in patients with ectopic ACTH syndrome. Clinical Endocrinology 27 483-492.
26. + dependent isoform of 11β-hydroxysteroid dehydrogenase. Endocrinology 131 970-972.
27. Walker BR, Stewart PM, Shackleton CHL, Padfield PL & Edwards CRW 1993 Deficient inactivation of Cortisol by 11β-hydroxysteroid dehydrogenase in essential hypertension. Clinical Endocrinology 39 221-227.
28. Walker BR, Williams BC & Edwards CRW 1994 Regulation of 11β-hydroxysteroid dehydrogenase activity by the hypothalamic-pituitary-adrenal axis in the rat. Journal of Endocrinology 141 467-472.
29. Walker BR, Connacher AA, Lindsay RM, Webb DJ & Edwards CRW 1995 Carbenoxolone increases hepatic insulin sensitivity in man: a novel role for 11-oxosteroid reductase in enhancing glucocorticoid receptor activation. Journal of Clinical Endocrinology and Metabolism 80 3155-3159.
30. Whitworth JA, Stewart PM, Burt D, Atherden SM & Edwards CRW 1989 The kidney is the major site of cortisone production in man. Clinical Endocrinology 31 355-361.
31. Whorwood CB, Mason JI, Ricketts ML, Howie AJ & Stewart PM 1995 Detection of human 11β-hydroxysteroid dehydrogenase isoforms using reverse transcription-polymer chain reaction and localisation of the type 2 isoform to renal collecting ducts. Molecular and Cellular Endocrinology 110 R7-R12.